CONFIDENTIAL TREATMENT REQUESTEDSale and Purchase Agreement • March 18th, 2016 • Glaxosmithkline PLC • Pharmaceutical preparations
Contract Type FiledMarch 18th, 2016 Company IndustryThe principles of interpretation set out in Clause 1 of the Original Agreement shall have effect as if set out in this Deed, save that references to “this Agreement” shall be construed as references to “this Deed”.
ContractSale and Purchase Agreement • January 27th, 2016 • Novartis Ag • Pharmaceutical preparations
Contract Type FiledJanuary 27th, 2016 Company IndustryConfidential portions of this exhibit have been omitted and filed separately with the Securities and Exchange Commission
21 November 2014 GLAXOSMITHKLINE PLC and NOVARTIS AGSale and Purchase Agreement • January 27th, 2015 • Novartis Ag • Pharmaceutical preparations
Contract Type FiledJanuary 27th, 2015 Company IndustryNo Brand name Active Ingredient Product Description Marketing Authorisation details (includes all countries that have product approval; NOTE; for products with multiple indications, some countries may not have yet have approval for all indications) Product Expansion Applications ( includes only those submitted or currently under regulatory review) ATC Code Dosage